Adagio Therapeutics burst onto the scene in 2020 led by biotech veteran Tillman Gerngross, Ph.D., and in direct response to the COVID pandemic. But in the intervening years, much has changed at the ...

Today Symphony Space, a U.S.-based aerospace pioneer, announced its official debut and the launch of the Adagio Platform, the world's first modular, multi-mission orbital infrastructure. Designed to ...

Title X is a federal grant program created to provide family planning and preventive health services to low-income people.

Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation ...

View source version on businesswire.com: https://www.businesswire.com/news/home/20260327740735/en/ The articles, information, and content displayed on this webpage ...

Tillman Gerngross has a simple goal: he wants to find one antibody that can both treat and prevent Covid-19, no matter how much the virus mutates. While many biotech companies are obsessed with making ...

Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced financial ...